On September 9, 2021, at 15.30 CEST, Estor is supporting a LIVE WEBINAR entitled “Immune Response in Acute and Chronic Patients and Role of Blood Purification Therapies”. The webinar is to be considered a scientific update and is aimed at healthcare professionals.
Estor is present at the 40th International Symposium on Intensive Care and Emergency Medicine (ISICEM), Aug 31 -Sept 3, 2021, Brussels, Belgium. TORAY is supporting a Symposium on August 31 from 12h30 to 13h30 which can also be followed on-line following registration.
The webinar entitled “Endotoxemia and role of Polymyxin B hemoperfusion in the cardiovascular intensive care unit” held in collaboration with ITACTA (Italian Association of Cardiothoracic Anaesthesiologists)is now available ON-DEMAND. This webinar aims to describe and discuss the pathogenic action of endotoxemia in various clinical contests of patients hospitalized in a cardiovascular intensive care unit and the role of Polymyxin B hemoperfusion as possible therapeutic option in adult and pediatric patients.
On April 15th, 2021, at 5pm (CEST), in collaboration with ITACTA (Italian Association of Cardiothoracic Anaesthesiologists) Estor is supporting an Italian language webinar entitled: “Endotoxemia and role of Polymyxin B hemoperfusion in the cardiovascular intensive care unit”.
This webinar aims to describe and discuss the pathogenic action of endotoxemia in various clinical contests of patients hospitalized in a cardiovascular intensive care unit and the role of Polymyxin B hemoperfusion as possible therapeutic option in adult and pediatric patients.
New relevant findings on the role of polymethylmethacrylate (PMMA)-based CVVH in an animal model of sepsis-induced AKI have been published in Frontiers in Immunology. The results show that PMMA-based CVVH significantly reduces tissue and systemic complement activation limiting renal damage and fibrosis highlighting the potential role of PMMA membrane as a therapeutic strategy in patients with septic acute kidney injury (AKI).
